A detailed history of Oliver Luxxe Assets LLC transactions in Pfizer Inc stock. As of the latest transaction made, Oliver Luxxe Assets LLC holds 18,410 shares of PFE stock, worth $472,216. This represents 0.1% of its overall portfolio holdings.

Number of Shares
18,410
Previous 18,626 1.16%
Holding current value
$472,216
Previous $521,000 2.11%
% of portfolio
0.1%
Previous 0.11%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$27.7 - $31.39 $5,983 - $6,780
-216 Reduced 1.16%
18,410 $532,000
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $1,591 - $1,864
63 Added 0.34%
18,626 $521,000
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $11,231 - $13,128
-350 Reduced 1.85%
18,563 $615,000
Q2 2023

Aug 01, 2023

SELL
$36.12 - $41.79 $33,952 - $39,282
-940 Reduced 4.73%
18,913 $693,000
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $2.72 Million - $3.54 Million
-69,089 Reduced 77.68%
19,853 $810,000
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $2,212 - $2,888
53 Added 0.06%
88,942 $4.56 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $45,116 - $55,076
1,031 Added 1.17%
88,889 $3.89 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $4,559 - $5,406
98 Added 0.11%
87,858 $4.61 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $9,607 - $11,904
-210 Reduced 0.24%
87,760 $4.54 Million
Q4 2021

Feb 16, 2022

SELL
$41.32 - $61.25 $70,491 - $104,492
-1,706 Reduced 1.9%
87,970 $5.2 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $130,349 - $167,444
3,321 Added 3.85%
89,676 $3.86 Million
Q2 2021

Jul 29, 2021

SELL
$35.91 - $40.68 $30,990 - $35,106
-863 Reduced 0.99%
86,355 $3.38 Million
Q1 2021

Apr 29, 2021

BUY
$33.49 - $37.77 $146,753 - $165,508
4,382 Added 5.29%
87,218 $3.16 Million
Q4 2020

Feb 04, 2021

SELL
$33.47 - $42.56 $362,747 - $461,265
-10,838 Reduced 11.57%
82,836 $3.13 Million
Q3 2020

Oct 20, 2020

BUY
$31.75 - $37.25 $88,138 - $103,406
2,776 Added 3.05%
93,674 $3.44 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $35,963 - $43,628
-1,194 Reduced 1.3%
90,898 $2.97 Million
Q1 2020

Apr 21, 2020

SELL
$27.03 - $38.62 $498,433 - $712,152
-18,440 Reduced 16.68%
92,092 $3.19 Million
Q4 2019

Feb 04, 2020

BUY
$32.92 - $37.36 $15,834 - $17,970
481 Added 0.44%
110,532 $4.33 Million
Q3 2019

Oct 15, 2019

BUY
$32.49 - $42.13 $251,700 - $326,381
7,747 Added 7.57%
110,051 $3.9 Million
Q2 2019

Jul 10, 2019

BUY
$36.98 - $41.52 $44,228 - $49,657
1,196 Added 1.18%
102,304 $4.43 Million
Q1 2019

May 01, 2019

SELL
$37.5 - $41.2 $124,275 - $136,536
-3,314 Reduced 3.17%
101,108 $4.29 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $274,021 - $312,414
-7,123 Reduced 6.39%
104,422 $4.56 Million
Q3 2018

Oct 10, 2018

SELL
$34.47 - $41.81 $186,896 - $226,693
-5,422 Reduced 4.64%
111,545 $5.01 Million
Q1 2018

Apr 17, 2018

SELL
$31.91 - $37.02 $189,736 - $220,120
-5,946 Reduced 4.84%
116,967 $4.15 Million
Q4 2017

Jan 16, 2018

SELL
$33.26 - $35.29 $47,195 - $50,076
-1,419 Reduced 1.14%
122,913 $4.45 Million
Q3 2017

Oct 23, 2017

BUY
$31.0 - $34.15 $3.85 Million - $4.25 Million
124,332
124,332 $4.44 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Oliver Luxxe Assets LLC Portfolio

Follow Oliver Luxxe Assets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.